Institutional Review Board (IRB)

for Posting Clinical Trials onto

For more information, please see the links below:

Box  New FDA/NIH Requirements Information Sheet
box  Clinical Trials Registration

On behalf of Georgetown University, the Institutional Review Board's (IRB) primary role is to safeguard the rights and welfare of all human subjects who participate in research studies conducted by Georgetown. In compliance with Federal law and institutional policy, all research projects involving human subjects or human material must be reviewed and approved by the IRB. All biomedical, social and behavioral research projects conducted by the faculty, the staff and students of the University are subject to the Policies and Procedures of the Institutional Review Board.

The Georgetown University IRB has the authority to disapprove, modify, or approve protocols based upon consideration of human subject protection. It also requires progress reports from the investigators at least annually and oversees the conduct of the study.

The overall criteria for IRB approval are:

  1. The risks to subjects are minimized as much as possible.
  2. The risks to subjects are reasonable in relation to anticipated benefits.
  3. The informed consent is adequate.
  4. Where appropriate, the research plan makes provisions for the safety of the subjects during the data collection process.
  5. Where appropriate, there are adequate provisions to protect the privacy of subjects and maintain confidentiality of data.
  6. Appropriate safeguards are included within the study to protect the rights and welfare of the vulnerable subjects.

Upcoming Events

Address & Hours


First Floor
SW104 Medical Dental Building
3900 Reservoir Road, NW
Washington, DC. 20057


M-F: 8:30am - 4:30pm
Sat, Sun: closed

Main IRB Office
Contact Information

Phone: (202) 687-1506
Fax: (202) 687-4847

Kristen Katopol, Director
Contact Information

Phone: (202) 687-0328